Banniere

ACS/AMO Congo : Access to treatment remains a priority

ACS/AMO CONGO:
ACCESS TO TREATMENT REMAINS A PRIORITY

May 13th, 2015

Photo: © Coalition PLUS Fqsida board member Hélène Legaré with the staff of ACS/AMO Congo’s “BON BERGER “ integrated polyclinic in Kinshasa (DRC), which provides some 2,300 persons living with HIV with anti-retroviral treatment, and medical and psycho-social care.

Photo: © Coalition PLUS
Fqsida board member Hélène Legaré with the staff of ACS/AMO Congo’s “BON BERGER “ integrated polyclinic in Kinshasa (DRC), which provides some 2,300 persons living with HIV with anti-retroviral treatment, and medical and psycho-social care.

The number of HIV-positive persons currently living in the Democratic Republic of Congo (DRC) is estimated at one million. Fewer than 100,000 of them receive anti-retroviral (ARV) treatment to fight the infection. This is a human, economic and health catastrophe when one knows that proper treatment enables a person to achieve quality of life and to be healthy enough to work on a daily basis and take care of his or her family, while considerably reducing the risk of transmission of the virus during sexual contact or from mother to child.
Historically, most people who are on ARVs in the DRC received them as a result of the mobilisation of community structures, with the ACS/AMO Congo foremost among them. Coalition PLUS has understood this and has been supporting this association since 2009 by financing the missions of independent auditors tasked with certifying it. Such a level of financial certification, very rare internationally, not only provides our organisation and its donors with a guarantee that the funds it manages are used rigorously, it also enables the member associations of Coalition PLUS to earn credibility with international donors in the fight against the epidemic.

Share on FacebookEmail this to someoneTweet about this on Twitter